Complications and Outcome
| Case . | Primary Acute GVHD . | Complications . | DLI . | GVHD After DLI . | Treatment of GVHD in Addition to Prophylaxis . | Current Status . | Cause of Death (d) . | |
|---|---|---|---|---|---|---|---|---|
| Starting Day . | Times/Total Dose of MNC (×106/kg) . | |||||||
| 1 | None | Sepsis, mucositis | (−) | — | (−) | (−) | Dead | Rejection, RRT (d 43) |
| 2 | None | None | (−) | — | (−) | (−) | Alive 937+ | |
| 3 | NE | VOD, renal failure, sepsis | (−) | — | (−) | (−) | Dead | VOD (d 17) |
| 4 | None3-150 | None | 34 | 5/1.4 | II | MPSL | Dead | Relapse (d 277) |
| 5 | None3-150 | Convulsion | 43 | 1/10 | IV | MPSL, FK506 | Dead | GVHD, sepsis (d 116) |
| 6 | II(d10−) | CMV cystitis | (−) | — | (−) | (−) | Alive 754+ | |
| 7 | III(d17−) | Convulsion | (−) | — | (−) | (−) | Alive 651+ | |
| 8 | NE | Sepsis, pyramidal sign | (−) | — | (−) | (− ) | Alive 594+ | Autologous recovery (Ph+ free) |
| 9 | None | None | 30 | 28/1204 | IV | MPSL | Dead | Peumonitis, MOF (d 363) |
| 10 | NE | None | (−) | — | (−) | (−) | Alive 476+ | Autologous recovery |
| 11 | None | None | (−) | — | (−) | (−) | Dead | Rejection, relapse (d 262) |
| 12 | NE | Sepsis, DIC | (−) | — | (−) | (−) | Dead | Sepsis (d 18) |
| 13 | None3-150 | Mucositis | 43 | 3/20.5 | I | None | Dead | Relapse (d 59) |
| Case . | Primary Acute GVHD . | Complications . | DLI . | GVHD After DLI . | Treatment of GVHD in Addition to Prophylaxis . | Current Status . | Cause of Death (d) . | |
|---|---|---|---|---|---|---|---|---|
| Starting Day . | Times/Total Dose of MNC (×106/kg) . | |||||||
| 1 | None | Sepsis, mucositis | (−) | — | (−) | (−) | Dead | Rejection, RRT (d 43) |
| 2 | None | None | (−) | — | (−) | (−) | Alive 937+ | |
| 3 | NE | VOD, renal failure, sepsis | (−) | — | (−) | (−) | Dead | VOD (d 17) |
| 4 | None3-150 | None | 34 | 5/1.4 | II | MPSL | Dead | Relapse (d 277) |
| 5 | None3-150 | Convulsion | 43 | 1/10 | IV | MPSL, FK506 | Dead | GVHD, sepsis (d 116) |
| 6 | II(d10−) | CMV cystitis | (−) | — | (−) | (−) | Alive 754+ | |
| 7 | III(d17−) | Convulsion | (−) | — | (−) | (−) | Alive 651+ | |
| 8 | NE | Sepsis, pyramidal sign | (−) | — | (−) | (− ) | Alive 594+ | Autologous recovery (Ph+ free) |
| 9 | None | None | 30 | 28/1204 | IV | MPSL | Dead | Peumonitis, MOF (d 363) |
| 10 | NE | None | (−) | — | (−) | (−) | Alive 476+ | Autologous recovery |
| 11 | None | None | (−) | — | (−) | (−) | Dead | Rejection, relapse (d 262) |
| 12 | NE | Sepsis, DIC | (−) | — | (−) | (−) | Dead | Sepsis (d 18) |
| 13 | None3-150 | Mucositis | 43 | 3/20.5 | I | None | Dead | Relapse (d 59) |
Abbreviations: NE, not evaluable; VOD, veno-occlusive disease; FK506, tacrolimus; MOF, multi-organ failure.
GVHD developed after DLI.